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Abstract: Modulation of mitochondrial free Ca2+ ([Ca2+]m) is implicated as
one of the possible upstream factors that initiates anesthetic-mediated
cardioprotection against ischemia-reperfusion (IR) injury. To unravel possible
mechanisms by which volatile anesthetics modulate [Ca 2+]m and
mitochondrial bioenergetics, with implications for cardioprotection,
experiments were conducted to spectrofluorometrically measure
concentration-dependent effects of isoflurane (0.5, 1, 1.5, 2 mM) on the
magnitudes and time-courses of [Ca2+]m and mitochondrial redox state
(NADH), membrane potential (ΔΨm), respiration, and matrix volume. Isolated
mitochondria from rat hearts were energized with 10 mM Na+- or K+pyruvate/malate (NaPM or KPM) or Na+-succinate (NaSuc) followed by
additions of isoflurane, 0.5 mM CaCl 2 (≈200 nM free Ca2+ with 1 mM EGTA
buffer), and 250 mM ADP. Isoflurane stepwise: (a) increased [Ca2+]m in state
2 with NaPM, but not with KPM substrate, despite an isoflurane-induced slight
fall in ΔΨm and a mild matrix expansion, and (b) decreased NADH oxidation,
respiration, ΔΨm, and matrix volume in state 3, while prolonging the duration
of state 3 NADH oxidation, respiration, ΔΨm, and matrix contraction with PM
substrates. These findings suggest that isoflurane's effects are mediated in
part at the mitochondrial level: (1) to enhance the net rate of state 2 Ca2+
uptake by inhibiting the Na+/Ca2+ exchanger (NCE), independent of changes
in ΔΨm and matrix volume, and (2) to decrease the rates of state 3 electron
transfer and ADP phosphorylation by inhibiting complex I. These direct effects
of isoflurane to increase [Ca2+]m, while depressing NCE activity and oxidative
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phosphorylation, could underlie the mechanisms by which isoflurane provides
cardioprotection against IR injury at the mitochondrial level.
Keywords: Cardiac IR injury, Anesthetics, Cardioprotection, Mitochondria,
Ca2+ uptake, Ca2+ efflux, Bioenergetics

Introduction
Ischemia-reperfusion (IR) injury results in mitochondrial
dysfunction, as shown by impaired mitochondrial ATP production and
dysregulation of mitochondrial Ca2+ homeostasis, resulting from
reduced membrane potential (ΔΨm), increased matrix swelling, release
of cytochrome c, and eventual cell membrane rupture and death [1–
4]. An increase in cytosolic free Ca2+ ([Ca2+]c), with a subsequent
increase in mitochondrial free Ca2+ ([Ca2+]m), is believed to be a major
contributor of mitochondrial dysfunction and mitochondria-mediated
cardiac cell injury or death during IR injury [4–6]. Therefore, the use
of drugs or cytoprotective strategies that interfere with cytosolic Ca2+
homeostasis could serve as an important strategy in cardioprotection
by delaying the onset of IR injury [3, 7, 8].
Anesthetic pre- and post-conditioning (APC and APOC) have
emerged as powerful strategies in cardioprotection against IR injury
[2, 8–10]. A better understanding of the mechanisms of anesthetics to
modify cardiac cell function may provide guidance on how to reduce or
delay cardiac cell injury caused by IR. Cardiac mitochondria are
believed to play an essential role in mediating cardioprotection by
anesthetics [2, 8, 11, 12]. Modulation of [Ca2+]m is believed to be one
of the upstream factors that initiate a cascade of protective kinases
during cardiac APC or APOC against IR injury [2, 4–7, 13]. In view of
the increasingly recognized role of mitochondria as initiators and
effectors of various cardioprotective signaling pathways, the effect of
isoflurane (a volatile anesthetic) to alter mitochondrial Ca2+ handling
and bioenergetics could provide novel insights into the mechanisms by
which anesthetics mediate cardioprotection against IR injury.
Ca2+ uptake via the Ca2+ uniporter (CU) is likely the primary
mode of Ca2+ entry into respiring mitochondria [14]; the Ca2+ entry is
dependent on [Ca2+]c, ΔΨm, and interference by other divalent cations
(e.g., Mg2+) that impede Ca2+ entry [15–17]. On the other hand,
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Na+/Ca2+ exchanger (NCE) serves as a principal Ca2+ efflux pathway
for maintaining mitochondrial Ca2+ homeostasis during physiological
and pathological conditions. Ca2+ is an integral component of the
signaling pathways involved in anesthetic-mediated cardioprotection
[2, 4, 6, 13]. However, how volatile anesthetics (e.g., isoflurane)
modulate the CU or other Ca2+ transporters (e.g., NCE) to alter
mitochondrial Ca2+ transients and bioenergetics that influence cellular
function, and how these effects relate to cardioprotection, have not
been explored.
The aim of this study was to investigate the direct effects of
isoflurane on mitochondrial Ca2+ uptake and release and associated
changes in bioenergetics that together, or singly, may underlie the
mechanisms of volatile anesthetic-mediated cardioprotection. Our
hypothesis was that isoflurane modulates [Ca2+]m, by modulating the
CU or NCE, in a ΔΨm- and matrix volume-independent manner, while
also altering the bioenergetic state. To test this hypothesis, we used
freshly isolated rat heart mitochondria energized with various
substrates (Na+- or K+-pyruvate/malate (NaPM or KPM) or Na+succinate (NaSuc)) and fluorescence techniques to investigate how
extra-matrix additions of 0.5 mM CaCl2 ([Ca2+]e ≈ 200 nM with 1 mM
EGTA buffer) and 250 mM ADP alter [Ca2+]m, NADH redox state,
respiration, ΔΨm, and matrix volume with several concentrations of
isoflurane (0, 0.5, 1, 1.5, 2 mM). We found that isoflurane has a
concentration-dependent effect to increase state 2 [Ca2+]m with NaPM,
but not with KPM substrate, and increase matrix volume and decrease
ΔΨm with all substrates, while depressing mitochondrial bioenergetics,
i.e., decreasing state 3 NADH oxidation, respiration,ΔΨm, and matrix
volume. These results indicate that isoflurane's effects are mediated in
part at the mitochondrial level to enhance the net rate of state 2 Ca2+
uptake by attenuating the activity of NCE, independent of ΔΨm and
matrix volume, and to inhibit complex I to decrease the rate and
prolong the duration of state 3 electron transport and ADP
phosphorylation.

Materials and Methods
Mitochondrial isolation
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The Medical College of Wisconsin Institutional Animal Care and
Use Committee (IACUC) approved the animal use and the
experimental protocols of this study. Rat heart mitochondria were
isolated by differential centrifugation methods, as described previously
for guinea pig hearts [18–20], with some minor modifications. Hearts
were isolated from Wistar rats (300–350g), anesthetized with sodium
thiobutabarbital (Inactin, Sigma-Aldrich, St. Louis, MO; 150 mg/kg
intraperitoneally), and were minced in ice-cold “isolation buffer”
containing (in mM) 200 mannitol, 50 sucrose, 5 KH2PO4, 5 3-(Nmorpholino) propanesulfonic acid (MOPS), and 1 EGTA, with 0.1%
bovine serum albumin (BSA) at pH 7.15 (adjusted with KOH). The
minced hearts were suspended in 2.5 ml isolation buffer with 5U/ml
protease and homogenized for 30 s. Next, 15 ml isolation buffer was
added and the suspension was homogenized further for 60 s. The
suspension volume was then adjusted to 25 ml and centrifuged at
8000 g for 10 min. The supernatant was discarded and the pellet was
resuspended in 25 ml isolation buffer and centrifuged at 700 g for 10
min. Next, the pellet was discarded and the supernatant was
centrifuged at 700 g for 10 min. The supernatant from this step was
centrifuged again at 8000 g for 10 min to yield the final mitochondrial
pellet, which was suspended in 0.5 ml isolation buffer and kept on ice
until used. All isolation procedures were carried out in a cold room
(4°C). The mitochondrial protein content was determined using BSA as
the standard with Biorad Quick Start Bradford Assay Kit [21].
Depending on the protein content, the suspension volume was
adjusted to have a protein concentration of 5 mg protein/ml isolation
buffer.

Indo-1 and DMSO loading
For [Ca2+]m measurements, mitochondria (5 mg protein/ml
isolation buffer) were incubated in 5 μM indo-1 AM for 20 min at 25°C
with constant stirring [18]. Next, the suspension volume was adjusted
to 25 ml and recentrifuged at 8000 g for 10 min to remove the
residual dye. The dye-loaded mitochondrial pellet was resuspended in
0.5 ml isolation buffer and kept on ice until used. Mitochondrial protein
content was redetermined and the suspension volume was readjusted
as described above. For bioenergetic measurements (respiration,
NADH, ΔΨm, and matrix volume), mitochondria were loaded with
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DMSO (vehicle for indo-1 AM; 0.1% final concentration) to mimic the
experimental conditions of indo-1 loaded mitochondria. All
experiments were conducted at room temperature (25°C), unless
otherwise stated.

Mitochondrial O2 consumption measurement
To test the functional integrity of mitochondria in day to day
experiments and also to examine the effect of isoflurane on states 2, 3
and 4 respiration, the rates of mitochondrial O2 consumption were
measured polarographically [18–20] at 30°C with a Clark type
electrode system (System S 200A; Strathkelvin Instruments, Glasgow,
UK). The DMSO or dye loaded mitochondria were suspended in
“respiration buffer” (0.5 mg protein/ml) containing (in mM) 130 KCl, 5
K2HPO4, 20 MOPS, 1 EGTA, and 0.1% BSA at pH 7.15 adjusted with
KOH. State 2 respiration was initiated with complex I substrate Na+pyruvate/malate (NaPM; 10 mM) in the presence of DMSO (vehicle) or
different concentrations of isoflurane (0.5, 1, 1.5, 2 mM) given prior to
substrate addition. State 3 respiration was measured by adding 250
μM ADP and state 4 respiration was measured after phosphorylation of
ADP to ATP. The time-line protocol for the respiration experiments is
shown in Fig. 1A. To test the functional integrity of mitochondria on a
given experimental day, the respiratory control index (RCI) was
calculated from the respiration rate ratio of state 3/state 2 or state
3/state 4. Mitochondrial preparations from hearts with DMSO or dye
incubation consistently provided RCIs of about 6 (state 3/state 2) and
4 (state 3/state 4). These mitochondria provided consistent data on
bioenergetics (respiration, NADH, Δψm, and matrix volume) and
[Ca2+]m in day to day experiments.
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Figure 1

Time-line protocols (in s) for isolated mitochondrial experiments. (A)

Respiration experiments, (B) [Ca2+]m, NADH, Δψm and matrix volume experiments,
and (C) Extended time-line protocol for [Ca2+]m measurements involving NCE kinetics.
Mito: mitochondria; PM: pyruvate/malate; DMSO: dimethyl sulfoxide; Iso: isoflurane;
CaCl2: calcium chloride; ADP: aden-osine diphosphate; FCCP: carbonyl cyanide ptrifluoromethoxyphenylhydrazone; CCCP: carbonylcyanide m-chlorophenylhydrazone;
Rot: rotenone; NCE: Na+/Ca2+ exchanger.

Mitochondrial redox state (NADH) measurement
The DMSO loaded mitochondria at a concentration of 0.5 mg
protein/ml respiration buffer were used to spectrophotometrically (PTI:
Photon Technology International, Birmingham, NJ) measure the timecourses of NADH during states 2, 3 and 4 respiration in the presence
of DMSO (vehicle) or isoflurane (0.5, 1, 1.5, 2 mM), given after
attaining state 2 respiration with NaPM, followed by 0.5 mM CaCl2
(≈200 nM free Ca2+) and 250 μM ADP. The time-courses of NADH
during states 2, 3 and 4 respiration were also assessed to compare
effects of complex I substrate (NaPM) and complex II substrate
(NaSuc) in the presence of DMSO, isoflurane (1 mM) or rotenone (30
nM), with and without 0.5 mM added CaCl2; 30 nM rotenone was used
to mimic the response of 1 mM isoflurane.
The time-line protocol for the NADH measurements is shown in
Fig. 1B. NADH was measured as autofluorescence [18, 19] by exciting
the mitochondrial sample at 350 nm (λex) and collecting the emission
signals (F) at 456 nm and 395 nm (λem). The λem's were switched
between two photon counters with a time resolution of 1 s. The F395
signals were less sensitive to the NADH changes, but account for light
scattering associated with matrix volume changes and/or
conformational changes, which were proportionally present in the F456
signals that are sensitive to the NADH changes. Therefore, the
fluorescence ratio (R =F456/F395) is interpreted as a measure of NADH
changes that corrects for artifacts due to changes in the light
scattering. Rotenone (1 μM) and FCCP (20 μM) were added in state 4
to obtain the end points for calibration of the NADH time-course
between maximally reduced and maximally oxidized states. The NADH
autofluorescence signals at the two respective wavelengths were also
used as background fluorescence signals for analyzing the indo-1 AM
fluorescence signals for [Ca2+]m measurements.
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Mitochondrial free Ca2+ ([Ca2+]m) measurement
The indo-1 loaded mitochondria (0.5 mg protein/ml respiration
buffer) were used in the same cuvette system (PTI) to
spectrophotometrically measure the time-courses of [Ca2+]m during
states 2, 3 and 4 respiration in the absence and presence of isoflurane
(0, 0.5, 1, 1.5, 2 mM), with the same time-line protocol as described
for NADH (Fig. 1B). In another set of experiments, the time-line
protocol for [Ca2+]m measurements was extended (Fig. 1C) to evaluate
the effects of 1 mM isoflurane on both Ca2+ uptake via the CU and Ca2+
efflux via the NCE, using the substrate KPM or NaPM with CGP-37157
(an inhibitor of NCE) present. Fluorescence signals with the DMSO (for
background autofluorescence, NADH) or indo-1 (for [Ca2+]m) loaded
mitochondria were obtained at the same excitation (λex=350 nm) and
emission (λem=395 and 456 nm) wavelengths. The signals from the
respective mitochondria were subtracted, time point by time point, to
correct for the effect of background autofluorescence (NADH) on indo1 fluorescence. The ratio of the two corrected signals (R =F395/F456)
accounted for individual signal variations as well as for the differences
in the amount of indo-1 taken up into the matrix in a given
experiment. The Rmax signal (maximum Ca2+ load that leads to
saturation of indo-1 dye with Ca2+) was determined by adding 0.5 μM
cyclosporine A (CsA, mPTP: mitochondrial permeability transition pore
blocker) and 5 mM CaCl2 to the respiring mitochondria; the Rmin signal
(zero Ca2+ load where all indo-1 dye become free of Ca2+) was
monitored with A23187 (a Ca2+ ionophore) that was added to the
mitochondria during state 2 respiration [18]. [Ca2+]m was calculated
using the standard calibration formula [22]: [Ca2+]m (nM) =Kd,app ·
Sf2/Sb2 · (R–Rmin)/ (Rmax–R); Kd,app (apparent dissociation constant for
dye-Ca2+ binding) was determined to be 330 nM at pH 7.15; Sf2 is the
signal intensity of free indo-1 measured at 456 nm and Sb2 is the
signal intensity of Ca2+-saturated indo-1 measured at 456 nm. The
ratio Sf2/Sb2, Rmax, and Rmin was measured independently for each
day's experiments.
For [Ca2+]m calibration, the measured Kd,app (330 nM) was
further corrected to account for pH changes that occur due to release
of protons from 1 mM EGTA present in the buffer with addition of 0.5
mM CaCl2. This correction was made using the formula Kd,app =Kd
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(1+[H+/]/KH), where KH is the dissociation constant for binding of
protons to indo-1, which is about 10−6.5 M or 315 nM, and Kd is the
true dissociation constant for binding of Ca2+ to indo-1, which is about
265 nM. Matrix pH was measured spectrofluorometrically in the same
PTI system using 2'7'-bis-(2-carboxyethyl)-5'(and 6-) carboxyfluroescein (BCECF) AM loaded mitochondria that leads to a pH
decrease of 0.07 units (data not shown) upon addition of 0.5 mM CaCl2
to 1 mM EGTA buffer. Accounting for this pH change, the Kd,app
increases from 330 nM to 344 nM.
Although matrix indo-1 fluorescence was measured during
states 2, 3 and 4 respiration, we show here only the [Ca2+]m timecourse during state 2 respiration. In a recent study [18], we observed
that matrix indo-1 fluorescence increases when ADP is added to the
buffer, and that fluorescence returns to the baseline (state 2) level
after ADP is phosphorylated to ATP; this results in an apparent
increase in [Ca2+]m during state 3 respiration [18]. However, the
mechanism of this increase in matrix indo-1 fluorescence, leading to
the apparent increase in [Ca2+]m, during state 3 respiration is unclear.
Therefore, we do not have an accurate measure of [Ca2+]m after ADP
addition (states 3 and 4).

Mitochondrial membrane potential (Δψm) measurement
Δψm was measured during states 2, 3 and 4 respiration in the
same PTI system using the fluorescent dye rhodamine 123 (Rh123; 50
nM; Calbiochem, San Diego, CA) in the buffer with λex =503 nm and
λem =527 nm [23]. Rh123 is a monovalent cation that is taken up into
the matrix of charged mitochondria where it accumulates due to a
large electronegative potential. An increase in Δψm is associated with a
decrease in fluorescence intensity. The DMSO loaded mitochondria
were suspended in respiration buffer (0.5 mg protein/ml) and the
time-course of Δψm was measured under various experimental
conditions with the same time-line protocol as for NADH and [Ca2+]m
(Fig. 1B). The uncoupler CCCP (4 μM) was added to maximally
(100 %) depolarize the mitochondria; Δψm at any time point was
expressed as a percentage of the fluorescence with maximal
depolarization.
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Mitochondrial matrix volume measurement
Changes in matrix volume as a consequence of changes in the
water and solute contents of the matrix after adding substrate, DMSO
or different concentrations of isoflurane, CaCl2, and ADP was measured
spectrofluorometrically in the same PTI system using light-scattering
technique [24, 25]. This was carried out by exciting the DMSO loaded
mitochondrial sample (0.5 mg protein/ml) at a particular wavelength
and collecting the emitted signals (photon counts) at the same
wavelength (e.g., λex = λem=520 nm). A decrease and increase in
photon counts due to light scattering is interpreted as the expansion
and contraction of matrix volume, respectively. The light scattering
signals were normalized with respect to their baseline levels (prior to
substrate addition). Because the signals at all wavelengths were
proportionally scattered (data not shown), we corrected the indo-1
fluorescence signals for NADH autofluorescence to accurately estimate
both NADH and [Ca2+]m.

Time-line protocols for experiments
Fig. 1A shows the time-line protocol for respiration
measurements, whereas Fig. 1B depicts the time-line protocol used for
NADH, [Ca2+]m, Δψm, and matrix volume measurements; Fig. 1C
shows the extended time-line protocol for [Ca2+m measurements
involving NCE kinetics. In all cases, the experiments were initiated at t
=0 with isolated mitochondria suspended in the respiration buffer (0.5
mg protein/ml). The time-course of states 2, 3 and 4 respiration was
monitored by adding to the mitochondrial sample DMSO (vehicle) or
isoflurane at t =30 s, followed by substrate (NaPM; 10 mM) at t =60 s
and ADP (250 μM) at t =120 s, which initiates state 3 respiration
proceeding to state 4 respiration after the conversion of ADP to ATP
(Fig. 1A). On the other hand, the time-courses of NADH, [Ca2+]m, Δψm,
and matrix volume were measured during each respiration state by
adding the substrate (NaPM; 10 mM or NaSuc; 10mM) at t =60 s,
followed by DMSO/isoflurane or rotenone (30 nM) at t =180 s, CaCl2 (0
or 0.5 mM) at t =300 s, and ADP (250 μM) at t =480 s (Fig. 1B). In
the extended time-line protocol for [Ca2+]m measurements for inferring
NCE kinetics (Fig. 1C), instead of ADP, the CU inhibitor ruthenium red
(RR; 25 μM) was added at t =480 s followed by the addition of NaCl
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(10 mM) at t =540 s. In NADH measurements, rotenone (1 μM) or
FCCP (20 μM) was added at t =660 s (state 4) to achieve maximally
reduced and maximally oxidized autofluorescence signals, respectively,
as the end points for NADH calibration. Similarly, in Δψm
measurements, CCCP (4 μM) was added at t =660 s to maximally
(100 %) depolarize the mitochondria, as the end point for Δψm
calibration. To account for the effects of DMSO alone, experiments
were conducted with a control group (no treatment) and the data were
compared to isoflurane and DMSO group data.
Isoflurane was dissolved in DMSO to achieve concentrations of
0.5, 1, 1.5 and 2 mM that correspond to 1, 2, 3 and 4 minimal alveolar
concentration (MAC), respectively, which are values commonly used
for surgical anesthesia. The actual isoflurane concentrations at the
beginning and end of each day's experiments were verified by gas
chromatography (GC). Average concentrations of isoflurane by GC
varied within ±10% of their initially prepared values of 0.5, 1, 1.5 and
2 mM.

Data analysis and statistics
All data were analyzed using computer programs written in
MATLAB that access the raw data of specific variables (NADH, [Ca2+]m,
Δψm, and matrix volume) from Excel® spread sheets of day to day
experiments generated from the PTI software. The programs
performed the necessary calculations to calibrate absolute values and
changes in variables from one state to the other, including statistical
analyses (i.e., computations of mean, standard deviation, and
standard error of a particular variable over multiple day experiments).
The program for [Ca2+]m calculations utilized both indo-1 fluorescence
signals and NADH autofluorescence signals for background and light
scattering corrections. The final data of a particular variable were
expressed as mean ± standard error (SE) over at least 4 replicates of
the same variable (n =4). Comparisons within and between groups
were performed by linear regression analysis, or by one-way ANOVA
(analysis of variance) with Tukey's post-hoc test for significance of
means. Differences with P < 0.05 (two-tailed) were considered
significant.
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Results
Isoflurane –induced decreases in mitochondrial
respiration
The concentration-dependent effect of isoflurane (0.5, 1, 1.5, 2
mM) on the time-courses of mitochondrial O2 concentration during
states 2, 3 and 4 respiration with NaPM is shown in Fig. 2A; the
corresponding rates of respiration (O2 consumption), RCIs (state
3/state 4 and state 3/state 2) that are measures of mitochondrial
integrity, and duration of state 3 respiration are summarized in Fig.
2B,C,D. Isoflurane significantly decreased state 3 respiration in a
concentration-dependent manner: 178 ±2.5, 159 ±2.3, 87 ±1.7 and
70 ±1.1 nmol mg−1 min−1 at 0.5, 1, 1.5 and 2 mM isoflurane,
respectively, when compared to the control (192 ±3) and DMSO (202
±3.1) groups, without appreciably changing state 2 or state 4
respiration among all groups (Fig. 2B). The effects of isoflurane on
state 3 respiration was also manifested in the computed RCIs (Fig. 2C)
and observed duration of state 3 respiration: 34 ±1 s, 41 ±2.1 s, 53
±1.7 s and 67 ±2.4 s at 0.5, 1, 1.5 and 2 mM isoflurane, respectively,
compared to the control (27 ±2 s) and DMSO (29 ±1.7 s) groups (Fig.
2D). This slowed rate and prolonged duration of state 3 respiration
with NaPM and increasing isoflurane concentration indicates a slower
rates of electron transport and ADP phosphorylation. However, the
amount of O2 consumed during state 3 respiration (ADP
phosphorylation) remained approximately constant, suggesting that
the P/O ratio remained approximately constant, ≈2.5.
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Figure 2

(A) Representative traces of time-course of mitochondrial O2

concentration during states 2, 3 and 4 respiration with isoflurane (0.5, 1, 1.5 and 2
mM) compared to control (no treatment) and vehicle (DMSO) groups. (B, C, D)
Summary of the effect of isoflurane, compared to DMSO (Iso = 0 mM), on the rates of
states 2, 3 and 4 O2 consumption, respiratory control indices (RCIs), and duration of
state 3 O2 consumption. Note that isoflurane caused a stepwise decrease in the rate of
state 3 O2 consumption (B), decreased the RCI that was defined as state 3/4
respiration and state 3/2 respiration to assess mitochondrial functional integrity by
isoflurane (C), and increased the duration of state 3 -induced O2 consumption (D),
consistent with an ADP-induced decrease in NADH oxidation and decline in Δψm (see
Figs. 3 and and5).5). The amount of O2 consumed during state 3 respiration (ADP
phosphorylation) remained approximately constant, suggesting that the P/O ratio
remained approximately constant (~2.5). Data are means ±SE of 3 replicates.

Isoflurane –induced changes in mitochondrial redox
state (NADH)
The concentration-dependent effect of isoflurane and 0.5 mM
CaCl2 (≈200 nM free Ca2+) on the time-courses of mitochondrial NADH
during states 2, 3 and 4 respiration with NaPM is shown in Fig. 3A. The
corresponding % NAD+ reduced with Ca2+, % NADH oxidized with ADP,
and duration of state 3 NADH oxidation are summarized in Fig. 3B,C,D.
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Isoflurane had little effect on NADH levels during state 2 or state 4
respiration as shown in the time-course tracings (Fig. 3A). Adding 0.5
mM CaCl2 caused a slight additional increase in state 2 NADH levels
(about 3%), independent of isoflurane concentration (Fig. 3B). Adding
ADP caused a significant oxidation of NADH in control and DMSO
groups; however, in the presence of isoflurane, ADP promoted a
pronounced isoflurane concentration-dependent decrease in state 3
NADH oxidation: 20 ±1.8, 15 ±2, 10 ±3 and 10 ±3% at 0.5, 1, 1.5
and 2 mM isoflurane, respectively, when compared to the control (29
±3%) or DMSO (29 ±4%) group (Fig. 3C). In addition, isoflurane also
significantly increased the duration of state 3 NADH oxidation: 78 ±8.2
s, 95 ±13.8 s, 104 ±15.3 s and 123 ±16 s at 0.5, 1, 1.5 and 2 mM
isoflurane, respectively, compared to the control (63 ±4.2 s) and
DMSO (65 ±4.8 s) group (Fig. 3D). This ADP-induced decrease in the
rate and increase in the duration of NADH oxidation with NaPM and
increased isoflurane concentration is consistent with the depressed
state 3 respiration due, in part, to slowed rates of electron transfer
and ADP phosphorylation; this is likely attributable to complex I
inhibition by isoflurane.

Figure 3

(A) Time-course of mitochondrial redox state (NADH) during states 2, 3

and 4 respiration with isoflurane (0.5, 1, 1.5 and 2 mM) compared to control (no
treatment) and vehicle (DMSO) groups. NADH state in each group was normalized on
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a scale of 0 (fully oxidized with FCCP) to 1 (fully reduced with rotenone) to express
NADH state as a % total pool of NAD + NADH. State 2 was subdivided into substrate
(S2sub), isoflurane (S2iso), and CaCl2 (S2Ca) effects. Adding ADP (250 μM) caused
NADH oxidation (state 3; S3) followed by recovery to state 4 (S4). Traces represent
means of 4 replicates in each group. (B, C, D) Summary of effects of 0. 5 mM added
CaCl2 (≈200 nM free Ca2+) on state 2 NADH reduction in the presence of isoflurane, of
isoflurane+ADP on state 3 NADH oxidation, and of isoflurane on duration of state 3
NADH oxidation; Isoflurane (0.5, 1, 1.5 and 2 mM) effect is compared to the DMSO
(Iso = 0 mM) effect. Note that adding CaCl2 caused further NADH reduction for all
isoflurane levels (B), ADP transiently oxidized NADH while isoflurane stepwise
decreased this level of oxidation (C), and that isoflurane stepwise increased the
duration of the state 3 -induced NADH oxidation (D). Data are means ±SE of 4
replicates. * indicates significant differences exist between isoflurane and
control/DMSO groups, while # indicates significant differences exist between high and
low isoflurane groups (p < 0.05).

To further evaluate that isoflurane inhibits complex I in our
model, the time courses of mitochondrial redox state (NADH) during
states 2, 3 and 4 respiration were measured and compared with
different substrates (NaPM, Fig. 4A,B; NaSuc, Fig. 4C,D), with 0.5 mM
added CaCl2 (≈200 nM free Ca2+) vs. no added CaCl2 (Fig. 4A,C vs.
Fig. 4B,D), and with isoflurane (1 mM), rotenone (30 nM), and vehicle
(DMSO). These data show that 1 mM isoflurane could mimic the
inhibition of complex I by 30 nM rotenone with both substrates and
extra-matrix CaCl2 perturbations. Furthermore, with NaSuc substrate,
the duration of state 3 NADH oxidation was longer with the DMSO
control than with either isoflurane (1 mM) or rotenone (30 nM) due to
inhibition of complex I.
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Figure 4

Time-courses of mitochondrial redox state (NADH) during states 2, 3 and

4 respiration comparing: effects of different substrates (Na+-pyruvate/malate (NaPM)
(A,B) and Na+-succinate (NaSucc) (C, D)); effects of 0.5 mM added CaCl2 (≈200 nM
free Ca2+) (A,C) vs. no added CaCl2 (B,D); and effects of isoflurane (1 mM) vs.
rotenone (30 nM) vs. vehicle (DMSO). NADH redox state was normalized in each group
as described in Fig. 3. Traces represent means of 4 replicates in each group. These
data demonstrate similarities in the effects of isoflurane and rotenone (a known
inhibitor of complex I activity), with different substrates and at different extra-matrix
and matrix Ca2+ ([Ca2+]e, [Ca2+]m).

Isoflurane –induced decreases in mitochondrial
membrane potential (Δψm)
The concentration-dependent effect of isoflurane and 0.5 mM
CaCl2 (≈200 nM free Ca2+) on the transients of Δψm during states 2, 3
and 4 respiration with NaPM is shown in Fig. 5A. The corresponding %
depolarization in Δψm with added isoflurane and ADP and duration of
state 3 Δψm depolarization are summarized in Fig. 5(B,C,D). Isoflurane
lowered Δψm during states 2, 3 and 4 respiration as shown in the timedependent traces (Fig. 5A). Isoflurane caused a slight concentrationdependent fall in Δψm in state 2 up to 2.7%, with negligible changes in
control and DMSO groups (Fig. 5B); adding 0.5 mM CaCl2 did not alter
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Δψm appreciably beyond the light scattering effects due to matrix
volume expansion. Addition of ADP caused a transient and reversible
phosphorylation-dependent depolarization of mitochondria in all
groups. Isoflurane increased the transient decrease in Δψm by ADP
(Fig. 5C) in a concentration-dependent manner, as well as prolonged
the duration of depolarization (Fig. 5D): from 71 ±5 s (control) and 71
±5 s (DMSO) to 83 ±2 s (Iso =0.5 mM), 112 ±5 s (Iso =1 mM), 147
±6 s (Iso =1.5 mM), and 181 ±4 s (Iso =2 mM). This observation of
isoflurane on ADP-induced falls in Δψm and rise in the duration of Δψm
depolarization with NaPM with increasing isoflurane concentration is
corroborated by the decreased rate and increased duration of state 3
respiration and NADH oxidation, which together reflects the effect of
isoflurane to slow the rates of electron transfer and ADP
phosphorylation.

Figure 5

(A) Time-course of mitochondrial membrane potential (ΔΨm) during

states 2, 3 and 4 respiration with isoflurane (0.5, 1, 1.5 and 2 mM) compared to
control (no treatment) and vehicle (DMSO) groups. ΔΨm was normalized with respect
to maximal (100%) depolarization obtained with CCCP. Traces represent means of 4
replicates in each group. (B, C, D) Summary of effects of isoflurane, compared to
DMSO (Iso = 0 mM), on state 2 ΔΨm, of isoflurane+ADP on state 3 ΔΨm, and of
isoflurane on state 3 duration of ΔΨm. Note that isoflurane caused a small stepwise
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decrease in state 2 ΔΨm (B), a stepwise decrease in state 3 ΔΨm (C), and a stepwise
increase in duration of the state 3 -induced decrease in ΔΨm (D). Data are means ±SE
of 4 replicates. * indicates significant differences exist between isoflurane and
control/DMSO groups, while # indicates significant differences exist between high and
low isoflurane groups (p < 0.05).

Isoflurane –induced changes in mitochondrial matrix
volume
The changes in matrix volume with additions of substrate
(NaPM; 10 mM), CaCl2 (0.5 mM) and ADP (250 μM) in control, DMSO
and isoflurane (0.5, 1, 1.5, 2 mM) groups are shown in Fig. 6A. The
corresponding % changes in matrix volume from baselines with added
CaCl2 and ADP and duration of state 3 volume change are summarized
in Fig. 6B,C,D. Isoflurane and CaCl2 each caused changes in matrix
volume during states 2, 3 and 4 respiration as shown in the timedependent traces (Fig. 6A); in general, isoflurane and CaCl2 caused
volume expansion, whereas ADP caused volume contraction.
Isoflurane induced a small dose-dependent volume expansion in state
2 compared to the control and DMSO groups; adding CaCl2 led to
further volume expansion in all groups (≈ 4–5%), nearly independent
of isoflurane concentration (Fig. 6B). Adding ADP caused volume
contraction that was dependent on isoflurane concentration (%): 6.7
±0.8 (control), 6.4 ±1.1 (DMSO), 7.9 ±1.1 (Iso =0.5 mM), 8.7 ±0.7
(Iso =1 mM), 10.3 ±1.1 (Iso =1.5 mM), and 9.9 ±1.3 (Iso =2 mM)
(Fig. 6C). Isoflurane increased the duration of ADP-induced volume
contraction from 48 ±0.3 s (control) and 49 ±0.9 s (DMSO) to 56 ±3 s
(Iso =0.5 mM), 68 ±2 s (Iso =1 mM), 86 ±5 s (Iso =1.5 mM), and
109 ±7 s (Iso =2 mM) (Fig. 6D). This increase in the duration of ADPinduced volume contraction with NaPM and increasing isoflurane
concentration is consistent with the increased durations of state 3
respiration (Fig. 2D), NADH oxidation (Fig. 3D), and Δψm
depolarization (Fig. 5D), each reflecting slower rates of electron flow
and ADP phosphorylation in the presence of isoflurane.
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Figure 6

(A) Time-course of matrix volume changes during states 2, 3 and 4

respiration with isoflurane (0.5, 1, 1.5 and 2 mM) compared to control (no treatment)
and vehicle (DMSO) groups. A decrease in light scattering photon counts signifies
volume expansion, while an increase signifies volume contraction. Light scattering
signals were normalized with respect to their baseline levels. Traces represent means
of 4 replicates in each group. Note that adding 0.5 mM CaCl2 (≈200 nM free Ca2+) had
only a slight effect to further promote volume expansion after isoflurane. (B,C,D)
Summary of effects of added CaCl2 on state 2 volume expansion in the presence of
isoflurane, of isoflurane+ADP on state 3 volume contraction, and of isoflurane on state
3 -induced volume contraction; Isoflurane (0.5, 1, 1.5 and 2 mM) effect is compared
to the DMSO (Iso = 0 mM) effect. Note that isoflurane caused further slight volume
expansion in state 2 after adding CaCl2 (B), isoflurane stepwise reduced the state 3 induced volume contraction (C), and isoflurane stepwise increased the state 3 induced duration of matrix contraction (D). Data are plotted as means ±SE of 4
replicates. * indicates significant differences exist between isoflurane and
control/DMSO groups, while # indicates significant differences exist between high and
low isoflurane groups (p < 0.05).
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Isoflurane –induced changes in mitochondrial free Ca2+
([Ca2+]m)
The concentration-dependent effect of isoflurane and 0.5 mM
CaCl2 (≈200 nM free Ca2+) on the dynamics of [Ca2+]m during states 2
respiration with NaPM is shown in Fig. 7A. The corresponding increases
in state 2 [Ca2+]m with added CaCl2 are summarized in Fig. 7B.
Isoflurane increased [Ca2+]m in a concentration-dependent manner
after adding 0.5 mM CaCl2 as shown in the time-dependent traces (Fig.
7A). The Na+-dependent substrate NaPM caused an initial small
decrease in [Ca2+]m from ~150 nM to almost 0 nM due to activation of
the NCE (Fig. 7A). Adding 0.5 mM CaCl2 during state 2 respiration
caused an increase in [Ca2+]m to 707 ±80 nM and 702 ±70 nM in the
control and DMSO groups, respectively, indicating that DMSO did not
itself alter [Ca2+]m (Fig. 7B). In the presence of isoflurane, [Ca2+]m
increased significantly over the control and DMSO values in a
concentration-dependent manner to 815 ±80 nM (Iso =0.5 mM), 960
±80 nM (Iso =1 mM), 1074 ±70 nM (Iso =1.5 mM), and 1158 ±70 nM
(Iso =2 mM) (Fig. 7B), despite the isoflurane-induced slight Δψm
depolarization (Fig. 5B) and mild matrix expansion (Fig. 6B) during
state 2 respiration.

Figure 7

(A) Time-course of mitochondrial free Ca2+ ([Ca2+]m) with 0.5 mM added

CaCl2 (≈200 nM free Ca2+) during state 2 respiration with Na+-pyruvate/malate
(NaPM) and isoflurane (0.5, 1, 1.5 and 2 mM) compared to control (no treatment) and
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vehicle (DMSO) groups. (B) Summary of the effects of adding CaCl2 on [Ca2+]m during
state 2 respiration with NaPM. Note that isoflurane had no effect on altering basal
[Ca2+]m but that [Ca2+]m was markedly elevated after adding CaCl2. Moreover,
isoflurane stepwise increased state 2 [Ca2+]m, compared to DMSO (Iso = 0 mM),
suggesting a net increase in Ca2+ uptake. (C) Time-course of [Ca2+]m with 0.5 mM
added CaCl2 (≈200 nM free Ca2+) and RR+10 mM added NaCl during state 2
respiration with substrates NaPM+CGP or KPM and isoflurane (1mM) compared to
DMSO. (D) Summary effect of adding CaCl2 and RR+NaCl on [Ca2+]m during state 2
respiration with KPM. Note that isoflurane did not induce any further increase in
[Ca2+]m, compared to DMSO, after adding CaCl2 with either substrates; however,
isoflurane attenuated matrix Ca2+ efflux, as assessed by decreased [Ca2+]m with NaCl
addition after blocking the CU with RR when using KPM substrate, indicating isoflurane
-induced attenuation of NCE activity. Traces represent means of 4 replicates in each
group and summary data are plotted as means ±SE of 4 replicates. * indicates
significant differences exist between isoflurane and control/DMSO groups, while #
indicates significant differences exist between high and low isoflurane groups (p <
0.05).

Isoflurane may differentially alter the activity of the
mitochondrial CU or NCE as a cause for the increased [Ca2+]m after
adding CaCl2 using NaPM substrate. To test this, [Ca2+]m was
measured with KPM vs. NaPM in the presence of a NCE inhibitor (CGP37157) at a single concentration of isoflurane (1 mM) vs. DMSO with
0.5 mM added CaCl2 (≈200 nM free Ca2+) followed by additions of RR
(25 μM) and NaCl (10 mM) (Fig. 7C,D). These data show that
isoflurane did not induce any further increase in [Ca2+]m (1153 ±58
nM) compared to DMSO (1189 ±66 nM) with the substrate KPM or
NaPM +CGP during the [Ca2+] uptake phase (t =450 s). However,
isoflurane attenuated matrix Ca2+ efflux, as assessed by decreased
[Ca2+]m, after blocking the CU with RR and then adding NaCl in the
KPM substrate experiments ([Ca2+]m =848 ±13 nM at t =600 s and
121 ±34 nM at t =900 s with DMSO vs. 987 ±41 nM at t =600 s and
237 ±57 nM at t =900 s with isoflurane) (Fig. 7D). The decrease in
[Ca2+]m induced by NaCl addition was totally negated when CGP was
used with the Na+-containing substrate (NaPM). These data thus
indicate that the isoflurane-mediated increases in [Ca2+]m with the
Na+-based substrate (NaPM) is a direct result of attenuated NCE
activity.

Discussion
The mitochondrion is recognized as an upstream target for
cardiac IR injury and a downstream effector of cardioprotection during
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volatile anesthetic-induced pre- and post-conditioning (APC, APOC) [2–
4, 6, 8]. The precise mechanisms of triggering, signaling and
mediation of the cardioprotective action of volatile anesthetics (e.g.,
isoflurane) involving mitochondria remain elusive. The direct effects of
isoflurane on mitochondrial bioenergetics and Ca2+ homeostasis was
the focus of this study with the aim to better understand the
mechanisms underlying the cardioprotective effect of volatile
anesthetics.
We used isolated cardiac mitochondria (respiring with different
substrates: NaPM, KPM and NaSuc) and fluorescence techniques to
study the effects of extra-matrix additions of 0.5 mM CaCl2 ([Ca2+]e
≈200 nM with 1 mM EGTA buffer) and 250 mM ADP on [Ca2+]m, NADH,
respiration, ΔΨm, and matrix volume at several concentrations of
isoflurane (0, 0.5, 1, 1.5, 2 mM). We found that isoflurane has several
direct and interrelated effects on mitochondrial function. Fore-most,
isoflurane exerts a concentration-dependent effect to reduce and slow
the rates of state 3 respiration and NADH oxidation, to further expand
state 2 and contract state 3 matrix volume, and to partially depress
states 2 and 3 ΔΨm. Moreover, isoflurane concentration-dependently
increases state 2 [Ca2+]m resulting from added CaCl2 with NaPM, but
not with KPM, substrate. The isoflurane-induced increases in state 2
[Ca2+]m with NaPM substrate, despite increasingly lower ΔΨm and
higher matrix volume, indicate that the apparent rise in Ca2+ influx, or
decline in Ca2+ efflux, across the inner mitochondrial membrane (IMM)
is more dependent on altered Ca2+ binding affinities of the two
principal Ca2+ transporters CU and NCE, and less dependent on
electrochemical gradient of Ca2+ across the (IMM) at increasing
isoflurane concentrations. Isoflurane is a very lipid soluble compound
that can modify protein structure. The use of KPM as substrate and an
NCE inhibitor demonstrate that isoflurane's effect to increase [Ca2+]m is
totally blocked, which strongly suggests that isoflurane decreases the
net efflux of Ca2+ by directly or allosterically attenuating NCE activity.
Our bioenergetic experiments support the notion that isoflurane also
inhibits complex I to decrease the rate and prolong the duration of
state 3 electron transfer and ADP phosphorylation, despite the lower
ΔΨm which would tend to enhance respiration.
In the context of cardioprotection, the isoflurane-mediated
attenuation of NCE activity leading to reduced net Ca2+ efflux (i.e.
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increased [Ca2+]m) could be an initiating factor in the sequence of
events leading to protection against IR injury. On the other hand,
isoflurane may mediate cardioprotection in large part by depressing
mitochondrial bioenergetics before, during, or after IR injury. It is not
clear from this study if isoflurane's effects to enhance [Ca2+]m while
depressing mitochondrial NCE activity and bioenergetics singularly or
together mediate cardioprotection. What appears evident from the
data is that isoflurane's effect to enhance [Ca2+]m exacerbates the
depression of the bioenergetic state by its influence to reduce ΔΨm.

Isoflurane depresses mitochondrial bioenergetics –
implications for cardioprotection
Altered mitochondrial function with APC or APOC has largely
been characterized by monitoring changes in NADH levels or
transporter/enzyme activities (e.g., complex I activity) that link to
other effectors being affected in triggering the protective mechanism
against myocardial IR injury. This notion is consistent with the
observation of a small sevoflurane-induced increase in NADH level in
isolated perfused guinea pig hearts [26]. In our isolated mitochondrial
study, isoflurane itself caused little change in state 2 NADH level,
whereas it greatly attenuated the extent of NADH oxidation during
state 3 respiration. This is most likely due to the slowed rates of
electron transfer and ADP phosphorylation so that the slower rate of
H+ pumping by NADH-linked intermediates is better matched to the
slower rate of H+ entering the matrix via complex V (F1F0-ATPase).
This would prolong the duration of state 3 ADP phosphorylation, which
is consistently reflected in the measured durations of state 3 NADH
oxidation, respiration, ΔΨm, and matrix contraction with complex I
substrates (NaPM or KPM).
Previous studies in isolated perfused hearts show that volatile
anesthetics attenuate electron transport chain (ETC) activity at the
level of complex I based on decreased NADH oxidation. This in turn is
thought to stimulate a small amount of ROS production and/or
activation of mitochondrial ATP-sensitive potassium channels (mKATP)
and mitochondrial calcium-sensitive potassium channels (mKCa) as
effectors in cardioprotection induced by anesthetics or other
compounds [27, 28]. Moreover, inhibition of complex I has been
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suggested as a likely target of volatile anesthetics in isolated cardiac
mitochondria [29–31] and in other experimental models [32–34]. Our
results on isoflurane-induced decreases in state 3 NADH oxidation and
respiration, and the accentuated fall in state 3 ΔΨm, indicate
attenuation of electron transfer and H+ pumping by ETC, especially at
complex I. This notion is substantiated by the measured time-courses
of matrix pH with BCECF-AM dye that showed no change in matrix pH
at different concentrations of isoflurane compared to the control and
DMSO groups (data not shown). This appears to rule out the possibility
that isoflurane has a protonophoric effect to allow H+ leak through the
IMM [35], which would itself enhance the respiratory rate, but which is
the opposite of what was observed.
To substantiate our view that isoflurane decreases state 3
electron transfer and ADP phosphorylation by inhibiting complex I, we
conducted bioenergetic experiments with both complex I substrate
(NaPM) and complex II substrate (NaSuc) with 0.5 mM added CaCl2 or
no added CaCl2 (Fig. 4A–D). Specifically, we compared the change in
NADH redox state with titrated concentrations of the complex I
inhibitor rotenone and found that 1 mM isoflurane mimicked inhibition
of complex I equivalent to 30 nM rotenone. These results demonstrate
similar effects of isoflurane (1 mM) and rotenone (30 nM) using
different substrates and at different [Ca2+]e and ([Ca2+]m.
Taken together, the available data support our observations that
isoflurane reduced mitochondrial bioenergetic activity by decreasing
NADH oxidation and ADP phosphorylation. In turn, this may ultimately
preserve the mitochondrial redox state needed for effective
mitochondrial ATP production during reperfusion [26]. The strategy of
targeting ETC complexes to modify electron transfer [34], and in part
ROS production from ETC complexes [1, 36], can also provide an
alternative strategy for cardioprotection by isoflurane.
Although not probed in this study, the possibility of a moderate
increase in ROS production while attenuating complex I activity cannot
be excluded, as isoflurane is shown here to moderately reduce O2
consumption in isolated mitochondria. Prior studies suggest a dual
effect of isoflurane on the ETC: mild uncoupling combined with
attenuated complex I activity [34, 37], and further effects on
complexes downstream of complex I, predominantly, complex III [38];
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the latter was suggested to trigger ROS production as a mechanism of
isoflurane-induced cardioprotection [4, 36]. A high NADH/NAD+ ratio in
the matrix is favorable to induce an increase in electron leak and ROS
production if electrons are blocked in the FeS clusters of the FMN
complex as a result of reduced NADH pool [39–41]. The small
decrease in ΔΨm induced by isoflurane implies that this may be a
direct or indirect factor in anesthetic-mediated cardioprotection [11,
12], at least in part by inhibiting the ROS production that can occur in
a highly reduced state [20, 42]. Attenuation of mitochondrial
respiration with isoflurane by inhibiting complex I may exert
cardioprotection [37, 43] by attenuating both ΔΨm and ROS production
[12, 44]. Thus, if isoflurane preserves the NADH pool by attenuating
complex I activity and stimulating NADH-induced ROS production, then
this could be an important trigger of cardioprotective pathways that
lead to protection against IR injury [45]. These direct effects may
contribute to the overall signaling cascade involved in APC and other
anesthetic-mediated cardioprotective strategies in which mitochondrial
ROS has been implicated as the critical trigger [8, 46]. Indeed,
mitochondrial ROS generation is influenced by [Ca2+]m, ΔΨm, and
redox state [1], and knowledge of how isoflurane directly modulates
mitochondrial function should provide novel insights into the
mechanisms of anesthetic-mediated cardioprotection [4].

Isoflurane enhances mitochondrial free Ca2+ ([Ca2+]m)
despite a decrease in membrane potential (Δψm) and
increase in matrix volume
Our study shows that isoflurane causes a slight concentrationdependent decrease in Δψm during state 2 respiration (Fig. 5). This
indicates that the observed increase in state 2 [Ca2+]m with increasing
isoflurane concentration in the NaPM substrate experiments (Fig. 7A,B)
is not solely dependent on Δψm for the electrochemical gradient to
promote enhanced Ca2+ influx into the matrix via the CU. In general,
Ca2+ uptake via the CU occurs at the expense of Δψm, i.e., it utilizes
the energy of Δψm to transport extra-matrix free Ca2+ across the IMM
[3, 47]. This is consistent with our previous study that showed a CaCl2
concentration-dependent increase in Ca2+ uptake, through the
ruthenium red-sensitive CU, in freshly isolated cardiac mitochondria at
a high Δψm [18]. Thus, one would expect that a decrease in Ca2+
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uptake would occur when Δψm is decreased, contrary to what we
observed in this study, indicating other possible mechanisms
associated with this increase in state 2 [Ca2+]m.
To further confirm that isoflurane increases state 2 [Ca2+]m with
NaPM substrate and is independent of Δψm, we added 0.5 mM CaCl2
and measured [Ca2+]m in the presence of an uncoupler, dinitrophenol
(DNP; 20 μM), and then added DMSO or 1 mM isoflurane. This data
showed that DNP, which induced partial Δψm depolarization decreased
[Ca2+]m; in contrast, isoflurane in the presence of DNP increased
[Ca2+]m despite partial Δψm depolarization (data not shown).
Since isoflurane and CaCl2 both led to matrix volume expansion
during state 2 respiration (Fig. 6), the increase in state 2 [Ca2+]m that
we observed with increasing isoflurane concentration in the NaPM
substrate experiments (Fig. 7A,B) may be somewhat underestimated
due to apparent decrease in indo-1 AM fluorescence by light
scattering. This indicates that the increase in state 2 [Ca2+]m is not due
to matrix volume contraction.
We examined other possibilities for increased state 2 [Ca2+]m
with isoflurane using NaPM as substrate. For example, there could
occur in an apparent increase in indo-1 AM fluorescence via an indo-1
and isoflurane interaction, via matrix Ca2+ buffering proteins, and/or
from decreased matrix pH via a possible protonophoric effect of
isoflurane. To test these possibilities, experiments were conducted in
triton-x treated indo-1 AM loaded mitochondria and BCECF-AM loaded
mitochondria in the presence of DMSO and isoflurane. Because we
found no change in indo-1 AM fluorescence as well as no change in
matrix pH at different concentrations of isoflurane compared to the
control and DMSO groups (data not shown), this ruled out these
possibilities. Also, with the minimal effect of isoflurane on state 2 Δψm
depolarization (2.7%), we would not expect substantial change in pH
as proton pumps must be working fast to maintain the same O2
consumption level. This was further confirmed by the observation of
very little change in state 2 respiration at different isoflurane
concentrations (Fig. 2A).
We also examined [Ca2+]m dynamics after adding CaCl2 using
the CU inhibitor RR, which was added before adding NaPM. This data
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(not displayed) did not demonstrate any increase in [Ca2+]m in control
(DMSO) or in isoflurane-treated mitochondria, thus excluding another
mechanism, i.e. isoflurane-induced alteration of indo-1 fluorescence,
as a cause for the increased [Ca2+]m in the presence of isoflurane.
Another possibility for increased state 2 [Ca2+]m with NaPM
substrate could arise from an effect of isoflurane to reduce matrix Ca2+
buffering by Ca2+ binding proteins. It is conceivable that isoflurane
may intercalate into the IMM and block Ca2+ binding proteins (e.g.,
annexin) to interact with the phospholipid bilayer through
phosphorylation [48, 49]. Though, we can not dismiss this possibility,
when isoflurane was added after CaCl2 in selected control and DMSO
experiments we did not see any further increase in [Ca2+]m (data not
shown). It is also unlikely that isoflurane might affect matrix Ca2+phosphate precipitate formation because the solubility product
constants for CaHPO4 and Ca3(PO4)2 formation are Ksp =10− and
3*10−30, respectively. With a matrix pH of around 7.2–7.3 and the
above Ksp values, [Ca2+]m would need to exceed 2 μM for any
appreciable amount of Ca2+-phosphate formation [50, 51].
From all the possibilities, we first concluded that the increases in
state 2 [Ca2+]m with increasing isoflurane concentration in the NaPM
substrate experiments (Fig. 7A,B) was most likely due to increased
influx or decreased efflux of Ca2+ across the IMM that involves direct or
allosteric activation of either the CU or inhibition of the NCE by
isoflurane. Because of isoflurane's high lipophilicity, it can directly or
indirectly (allosterically) interact with the lipids around the Ca2+
transporters or with their hydrophobic peptides to alter their binding
affinities of Ca2+. For example, we thought that isoflurane might
decrease the Km of Ca2+ for the CU and/or increase the Vmax of the CU
to increase binding of Ca2+ to the CU and/or enhance maximal activity
of the CU to promote enhanced Ca2+m uptake. Indeed, it was reported
that isoflurane activates mKATP channels reconstituted in lipid bilayers
[52] and that the mKATP channel blocker, 5-hydroxydecanoate (5-HD),
attenuates the cardioprotective effects of isoflurane in an isolated
perfused rabbit heart model [53]. In preliminary experiments we found
that the mKCa channel inhibitor paxilline had no effect on the
isoflurane-mediated rise in [Ca2+]m (data not shown).

Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 3 (March 2012): pg. 453-465. DOI. This article is © Elsevier
and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier.

28

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

To distinguish if isoflurane acts on the CU and/or the NCE to
increase [Ca2+]m after adding CaCl2 using the substrate NaPM, we also
measured [Ca2+]m using substrate PMK, or NaPM in the presence of
NCE inhibitor CGP-37157, with an extended time-line protocol (Fig.
1C). After energizing mitochondria with KPM or NaPM + CGP, the CU
inhibitor RR and then NaCl were added in the presence of DMSO or 1
mM isoflurane (Fig. 7C,D). In this protocol, isoflurane, like DMSO, did
not induce any further increase in [Ca2+]m after adding CaCl2;
moreover, NaCl had no effect to activate Ca2+ efflux as shown by no
further change in [Ca2+]m when using NaPM + CGP. When using KPM,
and after blocking the CU with RR, isoflurane attenuated the fall in
[Ca2+]m, i.e., decreased Ca2+m efflux, after adding NaCl to activate
NCE. These data showed clearly that the isoflurane-enhanced, CaCl2
induced, increase in state 2 [Ca2+]m with Na+-containing substrate
NaPM occurs primarily by attenuating the activity of the NCE. The
mechanism how isoflurane attenuates NCE activity (direct or indirect;
change in protein configuration; post-translational modification) is not
known at this time. However, this is the first report demonstrating that
a volatile anesthetic can attenuate matrix Ca2+ efflux, and explains in
part why we observed an increased [Ca2+]m despite a decrease in Δψm.
To provide additional evidence that the isoflurane-induced
increase in state 2 [Ca2+]m with NaPM as substrate results from
inhibited NCE activity, we monitored [Ca2+]e under the extended timeline protocol (Fig. 1C) to examine NCE kinetics under the conditions of
reduced buffer EGTA (40 μM) and added CaCl2 (30 μM) to elicit [Ca2+]e
responses comparable to the presented studies. Without the extensive
buffering of Ca2+ in the extra-matrix buffer, we could observe changes
in [Ca2+]e as Ca2+enters or exits the matrix. We found that isoflurane
did not alter the gradual fall in [Ca2+]e due to uptake via CU after the
fast initial rise due to adding CaCl2 but did attenuate the gradual rise
in [Ca2+]e after adding RR and then NaCl to stimulate NCE (data not
shown).

Implication of isoflurane-induced increased [Ca2+]m to
bioenergetics
[Ca2+]m is believed to enhance/stimulate mitochondrial
dehydrogenase enzymes, TCA cycle, and NADH production, and hence
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to increase state 3 respiration rate. Thus, it could be expected that the
CaCl2 –induced enhancement of [Ca2+]m by isoflurane would enhance
respiration and NADH, which it did not (Figs. 2–4). This discrepancy
may be attributed to several factors. First, 10 mM of substrate (NaPM
or KPM) to energize mitochondria may saturate the ADP-independent
TCA cycle flux. In a recent study [54], it was reported that to observe
an effect of increased Ca2+ to stimulate state 3 NADH production and
respiration, a low substrate concentration is necessary. Second, the
substrate glutamate +malate provides a greater NADH response to
increasing extra-matrix [Ca2+]. Third, state 2 [Ca2+]m after adding
CaCl2 in our study is about 700 nM with DMSO and rises to over 1000
nM after adding isoflurane (Figs. 7A,C), which may be high enough to
saturate the mitochondrial dehydrogenase enzymes [55], and hence
the TCA cycle flux that produce NADH for the ETC and OxPhos. Fourth,
isoflurane has another effect to attenuate complex I activity, which
itself leads to decreased electron flow and ADP phosphorylation during
state 3 respiration. Therefore, the increased state 2 [Ca2+]m that we
observe with isoflurane with saturating NaPM substrate concentration
(10 mM) would not be expected to increase state 3 respiration and
NADH oxidation. However, when we used 10 mM NaSuc as the
substrate we found that the duration of state 3 NADH oxidation was
shorter (faster respiration) after adding 1 mM isoflurane with or
without added CaCl2 (Fig. 4A–D).

Implication of isoflurane-induced increased [Ca2+]m to
cardioprotection
One might expect that a decrease in mitochondrial Ca2+ uptake
would occur when Δψm is decreased. Interestingly, in our study, a
decline in state 2 Δψm in the presence of isoflurane was associated
with a greater accumulation of Ca2+ in the matrix with NaPM substrate.
This suggests that isoflurane's cardioprotective effect is a result of an
indirect interplay between a mild decrease in Δψm due to slower
respiration and an enhanced net Ca2+ uptake, which tends to further
reduce Δψm. This notion is supported by our mitochondrial Ca2+ uptake
measurement in the presence of an uncoupler (DNP; 20 μM) and in the
presence of DMSO and isoflurane (1 mM), since DNP was suggested to
be cardioprotective [12]. Thus, a partial decrease in Δψm by isoflurane
during ischemia could preserve the H+ gradient necessary for efficient
Biochimica et Biophysica Acta: Bioenergetics, Vol. 1817, No. 3 (March 2012): pg. 453-465. DOI. This article is © Elsevier
and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from
Elsevier.

30

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

ATP synthesis to meet the energy demand of cardiomyocytes during
reperfusion to reduce IR injury.
Previous studies of volatile anesthetic-preconditioning of isolated
cardiomyocytes [11, 12, 56] and isolated perfused hearts [57]
demonstrate this therapy attenuates Ca2+m overload. In this case the
protective effects are measured after washout of the volatile
anesthetic that characterizes the memory phase of preconditioning. In
contrast, we focused here on the direct effects of a volatile anesthetic
on mitochondrial bioenergetics and Ca2+ handling, which showed an
increase in state 2 [Ca2+]m in the presence of isoflurane with NaPM as
substrate due to an attenuation of the NCE activity. This anestheticinduced increase in [Ca2+]m we observed may be part of a triggering
mechanism to initiate signaling pathways for preconditioning that may
translate into reduced Ca2+m uptake due to attenuated cytosolic Ca2+
overload and/or CU activity.
A recent study in isolated cardiomyocytes [12] showed that APC
affords protection against oxidative stress by attenuating Δψm that
leads to decreased ROS generation and attenuation of Ca2+m
accumulation; in contrast, in the present study in isolated cardiac
mitochondria, a similar decrease in Δψm resulted in an increase in
[Ca2+]m. The mechanism for an APC-mediated decrease in Δψm is not
clear. A large increase in [Ca2+]m is known to be deleterious as it leads
to mPTP opening during cardiac IR injury; paradoxically our study
implies that the small increases in [Ca2+]m elicited by isoflurane could
play a significant role in volatile anesthetic-mediated cardioprotection
by reducing electron flow and proton pumping, and thereby reducing
state 3 respiration, NADH oxidation, ADP phosphorylation, and Δψm.
Our finding that exposure of mitochondria to isoflurane showed
enhanced [Ca2+]m may seem to be anti-protective. Although Ca2+
overload initiates mPTP opening [58], the enhanced Ca2+ uptake with
isoflurane did not induce mPTP opening in this study as observed by
the return of the measured indices to state 4. However, isoflurane, by
depressing the bioenergetic state of mitochondria with the assistance
of a small increase in Ca2+ uptake, may activate signaling pathways
that reduce Ca2+ overload on reperfusion after ischemia [57] and
reduce activation of mPTP [57, 59]. Permanent opening of the mPTP is
thought to be induced or exacerbated by excess ROS emission [60]
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and/or excess Ca2+ loading. Opening of the mKATP channel may modify
Δψm [61] or matrix volume and pH [24, 62] to reduce the deleterious
Ca2+ overload.
Taking together, the mechanism(s) of cardiac protection
afforded by volatile anesthetics involves the interplay of [Ca2+]m
regulation, bioenergetic control, and possibly ROS emission. Our study
suggests that a moderate increase in [Ca2+]m coupled to depressed
mitochondrial bioenergetics may together be important factors in the
triggering phase of volatile anesthetic-mediated pre- and postconditioning, or in cardioprotection in general.

Highlights






We study mechanisms of isoflurane modulating mitochondrial
bioenergetics and [Ca2+]m.
Isoflurane increases state 2 [Ca2+]m independent of changes in
ΔΨm and matrix volume.
Increased [Ca2+]m is due to inhibition of mitochondrial Na+/Ca2+
exchanger (NCE).
Isoflurane decreases NADH oxidation, respiration, ΔΨm, and
matrix volume in state 3.
Isoflurane delays state 3 duration of bioenergetic variables by
complex I inhibition.
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